Mitra Medical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Mitra Medical
Largest movements
- Cash +€118,489
up €118,489 (+523%), from €22,640 to €141,129
mainly Net result for the year (+€71,293) and Receivables within one year (+€36,095)
- Receivables within one year -€36,095
down €36,095 (-49.5%), from €72,883 to €36,788
of which Other amounts receivable: -€38,095
- Reserves +€70,460
up €70,460 (+105%), from €67,059 to €137,519
- Tax, wage and social debts +€13,254
up €13,254 (+49.8%), from €26,592 to €39,846
of which Taxes: +€10,301
- Gross operating margin +€3,738
up €3,738 (+4.4%), from €84,984 to €88,721
- Financial income +€2,381
up €2,381 (+368%), from €648 to €3,029
- Taxes +€1,553
up €1,553 (+9.0%), from €17,282 to €18,835
- Depreciation +€1,068
up €1,068 (+1,353%), from €79 to €1,147
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €99,484 | €183,198 | +€83,714 | +84.1% |
| Fixed assets | 21/28 | €3,591 | €4,739 | +€1,148 | +32.0% |
| Tangible fixed assets | 22/27 | €3,591 | €4,739 | +€1,148 | +32.0% |
| Furniture and vehicles | 24 | €3,591 | €2,644 | -€947 | -26.4% |
| Other tangible fixed assets | 26 | - | €2,096 | +€2,096 | |
| Current assets | 29/58 | €95,893 | €178,459 | +€82,566 | +86.1% |
| Amounts receivable within one year | 40/41 | €72,883 | €36,788 | -€36,095 | -49.5% |
| Trade receivables | 40 | - | €2,000 | +€2,000 | |
| Other amounts receivable | 41 | €72,883 | €34,788 | -€38,095 | -52.3% |
| Cash at bank and in hand | 54/58 | €22,640 | €141,129 | +€118,489 | +523% |
| Deferred charges and accrued income | 490/1 | €370 | €542 | +€172 | +46.4% |
| Total equity and liabilities | 10/49 | €99,484 | €183,198 | +€83,714 | +84.1% |
| Equity | 10/15 | €72,059 | €142,519 | +€70,460 | +97.8% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €67,059 | €137,519 | +€70,460 | +105% |
| Distributable reserves | 133 | €67,059 | €137,519 | +€70,460 | +105% |
| Amounts payable | 17/49 | €27,425 | €40,679 | +€13,254 | +48.3% |
| Amounts payable within one year | 42/48 | €27,425 | €40,679 | +€13,254 | +48.3% |
| Taxes, remuneration and social security | 45 | €26,592 | €39,846 | +€13,254 | +49.8% |
| Taxes | 450/3 | €26,592 | €36,893 | +€10,301 | +38.7% |
| Remuneration and social security | 454/9 | - | €2,953 | +€2,953 | |
| Other amounts payable | 47/48 | €833 | €833 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €79 | €1,147 | +€1,068 | +1,353% |
| Other operating charges | 640/8 | €239 | - | -€239 | |
| Gross operating margin | 9900 | €84,984 | €88,721 | +€3,738 | +4.4% |
| Operating profit (loss) | 9901 | €84,665 | €87,575 | +€2,909 | +3.4% |
| Financial income | 75/76B | €648 | €3,029 | +€2,381 | +368% |
| Recurring financial income | 75 | €648 | €3,029 | +€2,381 | +368% |
| Financial charges | 65/66B | €139 | €476 | +€338 | +243% |
| Recurring financial charges | 65 | €139 | €476 | +€338 | +243% |
| Profit (loss) for the period before taxes | 9903 | €85,174 | €90,127 | +€4,953 | +5.8% |
| Income taxes | 67/77 | €17,282 | €18,835 | +€1,553 | +9.0% |
| Profit (loss) for the period | 9904 | €67,892 | €71,293 | +€3,400 | +5.0% |
| Profit (loss) for the period to be appropriated | 9905 | €67,892 | €71,293 | +€3,400 | +5.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.